Delphi Private Advisors’s Biogen BIIB Stock Holding History

Delphi Private Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	$1K	Buy	+5	New	+$1.16K	0.01%	79
2017 Q1	–	Sell	-10	Closed	-$3K	–	121
2016 Q4	$3K	Sell	10 -4	-29%	-$1.19K	0.01%	156
2016 Q3	$4K	Sell	14 -9	-39%	-$2.67K	0.01%	179
2016 Q2	$6K	Buy	23 +5	+28%	+$1.32K	0.01%	166
2016 Q1	$5K	Sell	18 -17	-49%	-$4.49K	0.01%	177
2015 Q4	$11K	Buy	+35	New	+$10.1K	0.02%	146

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Delphi Private Advisors's BIIB Position: Q2 2019 in Review

Delphi Private Advisors opened a new position in Biogen (BIIB) in Q2 2019: 5 shares worth $1K. The stake represents 0.01% of the portfolio and ranks #79 among its holdings. This is a return to the name: Delphi Private Advisors previously reported a position in BIIB as recently as Q4 2016.

Delphi Private Advisors first reported a position in BIIB in Q4 2015 and has held it in 6 quarters since. The position peaked at $11K in Q4 2015. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Delphi Private Advisors held 5 shares of Biogen worth $1K as of Q2 2019.
Biogen was a new Delphi Private Advisors position in Q2 2019.
Biogen made up 0.01% of Delphi Private Advisors's portfolio in Q2 2019, its #79 holding.
Delphi Private Advisors first reported a position in Biogen in Q4 2015 and has held it in 6 quarters since.
Delphi Private Advisors's Biogen position peaked at $11K in Q4 2015.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Delphi Private Advisors's 13F filing for Q2 2019, filed 17 Jul 2019.